Ikarian Capital »

Cybin shares owned by Ikarian Capital

Quarter-by-quarter ownership of Cybin shares owned by Ikarian Capital from 13F filings

Historical chart of Ikarian Capital investment in Cybin

Tip: Access up to 7 years of quarterly data

All positions including Cybin held by Ikarian Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cybin by Ikarian Capital

Quarter filed Position value Share count Share price at filing
2024-09-30 $3.3M 367k 8.89

More positions owned by Ikarian Capital

Vertex Pharmaceuticals Incorporated Put Option (VRTX)
Amgen Call Option (AMGN)
Spdr Ser Tr S&p Biotech Put Option (XBI)
Tarsus Pharmaceuticals (TARS)
Beigene Sponsored Adr Call Option (BGNE)
Anaptysbio Inc Common Put Option (ANAB)
Crinetics Pharmaceuticals In (CRNX)
Celldex Therapeutics Com New Put Option (CLDX)
Soleno Therapeutics Call Option (SLNO)
Janux Therapeutics Put Option (JANX)
Biohaven Put Option (BHVN)
Miragen Therapeutics Call Option (VRDN)
Immunovant Call Option (IMVT)
Capricor Therapeutics Com New Put Option (CAPR)
Arcus Biosciences Incorporated Call Option (RCUS)

View all positions for Ikarian Capital

Top funds holding Cybin

Avidity Partners Management
Octagon Capital Advisors
Tang Capital Management
Ikarian Capital
PDS Planning
Alyeska Investment Group
Jane Street
Fore Capital
TD Waterhouse Canada
IAG Wealth Partners
Royal Bank of Canada
Bank of America Corporation
Crewe Advisors
Global Wealth Strategies & Associates
Advisor Group Holdings

View all funds holding Cybin